標(biāo)題: Titlebook: Diabetes and COVID-19; Considerations and C Alyson K. Myers Book 2023 The Editor(s) (if applicable) and The Author(s), under exclusive lice [打印本頁] 作者: digestive-tract 時(shí)間: 2025-3-21 16:46
書目名稱Diabetes and COVID-19影響因子(影響力)
書目名稱Diabetes and COVID-19影響因子(影響力)學(xué)科排名
書目名稱Diabetes and COVID-19網(wǎng)絡(luò)公開度
書目名稱Diabetes and COVID-19網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Diabetes and COVID-19被引頻次
書目名稱Diabetes and COVID-19被引頻次學(xué)科排名
書目名稱Diabetes and COVID-19年度引用
書目名稱Diabetes and COVID-19年度引用學(xué)科排名
書目名稱Diabetes and COVID-19讀者反饋
書目名稱Diabetes and COVID-19讀者反饋學(xué)科排名
作者: 諷刺 時(shí)間: 2025-3-22 00:03
2523-3785 vascular surgery, pulmonary/critical care, and general medicine..Written by experts in the field, .Diabetes and COVID-19: Considerations and Clinical Management. is a blueprin978-3-031-28538-7978-3-031-28536-3Series ISSN 2523-3785 Series E-ISSN 2523-3793 作者: Coronary 時(shí)間: 2025-3-22 01:32
International vergleichende Armutsforschunge different molecular, antigen, and serologic tests for the diagnosis of COVID-19. Most cases of COVID-19 require only supportive care; however, in patients with increased risks factors for complications and for those with moderate to severe disease, specific therapeutic options that include antivir作者: groggy 時(shí)間: 2025-3-22 06:29 作者: 相同 時(shí)間: 2025-3-22 10:12
Gesellschaftliche Ein- und Ausgrenzungicious fluid and electrolyte management is indicated. To help further reduce the need for potential viral exposure, early data suggests the clinical efficacy and safety of continuous glucose monitoring (CGM) in the management of critically ill patients with COVID-19 disease.作者: 輕快走過 時(shí)間: 2025-3-22 14:17
https://doi.org/10.1007/978-3-662-45196-0 and strategies for prevention including social distancing and vaccination. Ambulatory providers must also be sensitized to unmet social needs like food and financial insecurity that can impact the patient’s health choices and thus disease management. Providers must adapt to using technologies such 作者: 輕快走過 時(shí)間: 2025-3-22 18:11 作者: PIZZA 時(shí)間: 2025-3-22 21:13 作者: Corporeal 時(shí)間: 2025-3-23 02:38
Pathophysiology: How COVID-19 Impacts the Pancreas and Peripheral Insulin Resistanceanied by extremely high insulin requirements to normalize blood glucose in the hospital, consistent with severe insulin resistance. How insulin resistance colludes with potential impairments in islet function and insulin secretion and the development of incident diabetes or deterioration of glycemic作者: BLINK 時(shí)間: 2025-3-23 06:00 作者: OWL 時(shí)間: 2025-3-23 10:50 作者: 憤怒歷史 時(shí)間: 2025-3-23 17:53
Long-Haul COVID Symptoms in Persons with Diabetesoms are fatigue, dyspnea, and cognitive dysfunction..It is well known that individuals with pre-existing diabetes are at higher risk of complications during the acute phase of COVID-19, but few studies have investigated the presence of long COVID symptoms in subjects with pre-existing diabetes. Alth作者: motivate 時(shí)間: 2025-3-23 21:51
COVID-19: Epidemiology, Etiology, Clinical Manifestations, Diagnosis, Therapeutic Options, and Prevehat has caused significant mortality and morbidity worldwide. The most common method of transmission is through respiratory droplets from person to person, yet direct contact and airborne transmission have been reported. The incubation period is usually 2–14?days with a median of 5?days. Initial sym作者: CLOWN 時(shí)間: 2025-3-24 01:10
Pathophysiology: How COVID-19 Impacts the Pancreas and Peripheral Insulin Resistanceection. The contribution of COVID-19-related destruction of beta-cells or islet vasculature is supported by preclinical studies and autopsy studies. Available evidence supports a multifaceted insult to the pancreas in the context of COVID-19. Whether the vasculature or the beta-cell is the primary t作者: 廣大 時(shí)間: 2025-3-24 03:08
Risk of COVID-19 in Persons with Diabetesersons with diabetes. Also, the risk of new-onset diabetes in the setting of COVID-19 is examined, followed by the risk of COVID-19 in individuals with different types of diabetes including prediabetes, pediatric diabetes, type 1 and type 2 diabetes, and gestational diabetes. Lastly, complications a作者: 迷住 時(shí)間: 2025-3-24 08:53
Pathophysiology of Lung Dysfunction in Diabetesmic. Acute respiratory distress syndrome marked by severe hypoxemic respiratory failure was observed in COVID-19 in people with and without underlying lung disease. Knowledge gaps exist as to how co-existing diabetes and lung disease share molecular and clinical pathways with each other and with COV作者: peritonitis 時(shí)間: 2025-3-24 12:59 作者: Prostatism 時(shí)間: 2025-3-24 18:13 作者: LIMIT 時(shí)間: 2025-3-24 21:53 作者: 躺下殘殺 時(shí)間: 2025-3-25 02:32 作者: Kaleidoscope 時(shí)間: 2025-3-25 05:21
Management of Critically Ill Persons with COVID-19 and Diabetesar hyperglycemic state (HHS), especially in patients with diabetes. While?treatment with a continuous insulin infusion is traditionally considered to be the standard of care in DKA management, subcutaneous insulin protocols have been utilized during the pandemic for treating mild-to?moderate DKA wit作者: 委屈 時(shí)間: 2025-3-25 08:38 作者: judiciousness 時(shí)間: 2025-3-25 14:21
The Use of Diabetes Technology in Persons with Diabetes and Coronavirus 2019ommunity and/or public health-care spaces is warranted. In addition, diabetes technologies including cloud-based glucose monitors and insulin delivery systems, which digitally store information about insulin dosing and delivery that can be uploaded to the cloud and accessed remotely by providers, ha作者: 全國性 時(shí)間: 2025-3-25 16:22 作者: carbohydrate 時(shí)間: 2025-3-25 20:56
COVID-19 Vaccination in Persons with Diabetes: How they Workod of severe infection and mortality. We have reviewed the associations of diabetes with immune response to COVID-19 itself and to the COVID-19 vaccine, as well as discussed the existing evidence of the efficacy of the vaccine in persons with diabetes. Immunity to vaccination appears to decline more作者: 臨時(shí)抱佛腳 時(shí)間: 2025-3-26 01:08 作者: 無動(dòng)于衷 時(shí)間: 2025-3-26 06:18
Pathophysiology of Lung Dysfunction in DiabetesID-19. This chapter focuses on major disease mechanisms common to lung illnesses and diabetes and aims to connect these disease processes with our current understanding of COVID-19. We explore diabetes in association with COVID-19, asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, thromboembolic disease, and bronchiectasis.作者: Exploit 時(shí)間: 2025-3-26 10:18
The Impact of COVID-19 on Diabetic Foot Ulcershe field of managing patients with DFU and accelerated the establishment of once-novel forms of treatment. This chapter will review the presentation and management of DFU with special insights into the role the pandemic played in delivering care.作者: 歌曲 時(shí)間: 2025-3-26 12:38 作者: Certainty 時(shí)間: 2025-3-26 16:57 作者: 易受騙 時(shí)間: 2025-3-26 22:49 作者: EXALT 時(shí)間: 2025-3-27 03:52
Einkommen und soziale Ausgrenzung Due to underlying risk factors and immunosuppression, these patients have an increased risk for severe COVID-19. This chapter will review the complex interplay between COVID-19 and the kidney, with a focus on patients with DKD and kidney transplantation.作者: 鉆孔 時(shí)間: 2025-3-27 06:23
Klaus Br?unig,Ralf Scheibach LLMrm compatibility between technologies. Data regarding the benefits of continuous glucose monitoring (CGM) in the hospital for COVID-19-infected patients are growing; however, evaluation of benefits and barriers will need to occur for this technology to become standard of care in the inpatient setting for people with diabetes and COVID-19.作者: Armory 時(shí)間: 2025-3-27 13:08
Handbuch Au?enpolitik ?sterreichshe duration of vaccines, the impact vaccines have had on hospitalization and mortality in persons with diabetes and COVID-19, and strategies to improve vaccine confidence in patients living with diabetes.作者: asthma 時(shí)間: 2025-3-27 15:17
Diabetic Kidney Disease and COVID-19 Due to underlying risk factors and immunosuppression, these patients have an increased risk for severe COVID-19. This chapter will review the complex interplay between COVID-19 and the kidney, with a focus on patients with DKD and kidney transplantation.作者: amyloid 時(shí)間: 2025-3-27 21:30 作者: 牲畜欄 時(shí)間: 2025-3-27 22:10
COVID-19 Vaccination in Persons with Diabetes: How to Approach Patientshe duration of vaccines, the impact vaccines have had on hospitalization and mortality in persons with diabetes and COVID-19, and strategies to improve vaccine confidence in patients living with diabetes.作者: Osteoarthritis 時(shí)間: 2025-3-28 02:21
Risk of COVID-19 in Persons with Diabetesh different types of diabetes including prediabetes, pediatric diabetes, type 1 and type 2 diabetes, and gestational diabetes. Lastly, complications and mortality associated with SARS-CoV-19-infected individuals with diabetes are further explored.作者: calorie 時(shí)間: 2025-3-28 09:19 作者: 條約 時(shí)間: 2025-3-28 11:47
https://doi.org/10.1007/978-3-531-90906-6ID-19. This chapter focuses on major disease mechanisms common to lung illnesses and diabetes and aims to connect these disease processes with our current understanding of COVID-19. We explore diabetes in association with COVID-19, asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, thromboembolic disease, and bronchiectasis.作者: ascend 時(shí)間: 2025-3-28 18:39 作者: PATRI 時(shí)間: 2025-3-28 19:27 作者: 艱苦地移動(dòng) 時(shí)間: 2025-3-29 00:34 作者: paradigm 時(shí)間: 2025-3-29 04:50 作者: 跳動(dòng) 時(shí)間: 2025-3-29 09:09 作者: Cabinet 時(shí)間: 2025-3-29 14:18 作者: FAZE 時(shí)間: 2025-3-29 18:01 作者: negligence 時(shí)間: 2025-3-29 21:31 作者: Credence 時(shí)間: 2025-3-30 03:50 作者: 侵害 時(shí)間: 2025-3-30 06:47
https://doi.org/10.1007/978-3-531-90906-6mic. Acute respiratory distress syndrome marked by severe hypoxemic respiratory failure was observed in COVID-19 in people with and without underlying lung disease. Knowledge gaps exist as to how co-existing diabetes and lung disease share molecular and clinical pathways with each other and with COV
